Bank of Nova Scotia
EW icon

Bank of Nova Scotia’s Edwards Lifesciences EW Stock Holding History

Bank of Nova Scotia’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35,100
Closed -$4.13M – 1192
2022
Q1 		$4.13M Sell
35,100
-3,420
-9% -$384K 0.01% 634
2021
Q4 		$5.03M Buy
38,520
+5,210
+16% +$608K 0.01% 699
2021
Q3 		$3.77M Buy
33,310
+10,310
+45% +$1.18M 0.01% 695
2021
Q2 		$2.38M Buy
+23,000
New +$2.17M ﹤0.01% 780

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of Nova Scotia's EW Position: Q2 2026 in Review

Bank of Nova Scotia reduced its Edwards Lifesciences (EW) stake by 25% in Q2 2026, selling an estimated $1.71M and leaving 60,417 shares worth $5.47M. The position accounts for 0.01% of the portfolio, ranked #605.

Bank of Nova Scotia first reported a position in EW in Q4 2014 and has held it in 46 quarters since. The position peaked at $136M in Q4 2021. 973 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bank of Nova Scotia held 60,417 shares of Edwards Lifesciences worth $5.47M as of Q2 2026.
  • Bank of Nova Scotia sold 20,437 Edwards Lifesciences shares in Q2 2026, an estimated $1.71M.
  • Edwards Lifesciences made up 0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #605 holding.
  • Bank of Nova Scotia first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 46 quarters since.
  • Bank of Nova Scotia's Edwards Lifesciences position peaked at $136M in Q4 2021.
  • 973 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.